Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
78
Views
4
CrossRef citations to date
0
Altmetric
Original Research

CIP2A overexpression in Taiwanese oral cancer patients

Bharath Kumar Velmurugan1 Faculty of Applied Sciences, Ton Duc Thang University, Ho Chi Minh City, Vietnam
,
Hsin-Kai Wang2 Public Health Bureau, Tainan City Government, Tainan City, Taiwan;3 Jenteh Junior College of Medicine, Nursing and Management, Taiwan
,
Chia-Min Chung4 Graduate Institute of BioMedical Sciences, China Medical University, Taichung, Taiwan;5 Environment-Omics-Diseases Research Center, China Medical University Hospital, Taichung, Taiwan
,
Chien-Hsun Lee6 Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan
,
Lan-Ru Huang7 School of Medicine, Chung Shan Medical University, Taichung, Taiwan
,
Kun-Tu Yeh6 Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan;7 School of Medicine, Chung Shan Medical University, Taichung, TaiwanCorrespondence[email protected] [email protected]
&
Shu-Hui Lin6 Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan;8 Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan
 show all
Pages 2589-2594 | Published online: 05 Apr 2019

References

  • Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–316. doi:10.1016/j.oraloncology.2008.06.00218804401
  • Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008;44(1):10–22. doi:10.1016/j.oraloncology.2007.06.01117825602
  • Xu ST, Wen WJ, Zhou J, Liu JX, Gu GJ. Clinicopathological significance of expression of CIP2A and c-myc in human gallbladder carcinoma. Int J Clin Exp Patho. 2017;10(5):5868–5874.
  • Khanna A, Bockelman C, Hemmes A, et al. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. J Natl Cancer Inst. 2009;101(11):793–805. doi:10.1093/jnci/djp10319470954
  • Come C, Laine A, Chanrion M, et al. CIP2A is associated with human breast cancer aggressivity. Clin Cancer Res. 2009;15(16):5092–5100. doi:10.1158/1078-0432.CCR-08-328319671842
  • Xu P, Xu XL, Huang Q, Zhang ZH, Zhang YB. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis. Med Oncol. 2012;29(3):1643–1647. doi:10.1007/s12032-011-0053-321874565
  • Bockelman C, Hagstrom J, Makinen LK, et al. High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer. Brit J Cancer. 2011;104(12):1890–1895. doi:10.1038/bjc.2011.16721610708
  • Ventela S, Sittig E, Mannermaa L, et al. CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance. Oncotarget. 2015;6(1):144–158. doi:10.18632/oncotarget.267025474139
  • Katz J, Jakymiw A, Ducksworth MK, et al. CIP2A expression and localization in oral carcinoma and dysplasia. Cancer Biol Ther. 2010;10(7):694–699. doi:10.4161/cbt.10.7.1289521068540
  • Hsu LS, Wu PR, Yeh KT, et al. Positive nuclear expression of KLF8 might be correlated with shorter survival in gastric adenocarcinoma. Ann Diagn Pathol. 2014;18(2):74–77. doi:10.1016/j.anndiagpath.2013.12.00124461703
  • Rantanen T, Kauttu T, Akerla J, et al. CIP2A expression and prognostic role in patients with esophageal adenocarcinoma. Med Oncol. 2013;30:3. doi:10.1007/s12032-013-0684-7
  • Dong QZ, Wang Y, Dong XJ, et al. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis. Ann Surg Oncol. 2011;18(3):857–865. doi:10.1245/s10434-010-1313-820842459
  • Junttila MR, Puustinen P, Niemela M, et al. CIP2A inhibits PP2A in human malignancies. Cell. 2007;130(1):51–62. doi:10.1016/j.cell.2007.04.04417632056
  • Cha GQ, Xu JY, Xu XY, et al. High expression of CIP2A protein is associated with tumor aggressiveness in stage I-III NSCLC and correlates with poor prognosis. Onco Targets Ther. 2017;10:5907–5914. doi:10.2147/OTT.S14825029276394
  • He H, Wu G, Li WJ, Cao YC, Liu YF. CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis. Diagn Mol Pathol. 2012;21(3):143–149. doi:10.1097/PDM.0b013e3182-49fd8b22847158
  • Bockelman C, Lassus H, Hemmes A, et al. Prognostic role of CIP2A expression in serous ovarian cancer. Brit J Cancer. 2011;105(7):989–995. doi:10.1038/bjc.2011.34621897396
  • Ren J, Li W, Yan L, et al. Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients’ survival. Brit J Cancer. 2011;105(12):1905–1911. doi:10.1038/bjc.2011.49222075943
  • Yu GZ, Liu GH, Dong J, Jin YY. Clinical implications of CIP2A protein expression in breast cancer. Med Oncol. 2013;30:2. doi:10.1007/s12032-013-0524-9
  • Liu N, He QM, Chen JW, et al. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth. Mol Cancer. 2014;13:111.24884612

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.